AI‐Driven Drug Discovery and Repurposing for Analyzing Long‐Term Effects of Nerve Sliders and Tensioners on Quality of Life in Cervicogenic Headache Patients

These days, headaches are a significant cause of suffering and impairment. The World Health Organization claims that headaches are sort of stress on people's health that affects people all over the world but are more prevalent in Western culture. This experimental study was conducted at Swami Rama Himalayan Hospital in Jolly Grant, with a sample size of 38 participants, including staff and students from Himalayan Institute of Hospital Trust (HIHT), over a period of six months. The study focused on using artificial intelligence (AI) for drug delivery, utilizing biomarkers to tailor treatments according to the needs for chronic gastrointestinal health (CGH). In the present big data era, the development of machines or AI now serves as a guide for early-stage medication design and discovery. As of right now, these kinds of success stories give us ample proof that AI will really fulfill its enormous promise of speeding up the development of new drugs. Additionally, AI speeds up the repurposing or repositioning of drugs, and, all things considered, AI techniques are essential and unavoidable instruments in the creation of novel medicines.